Two Sigma Securities, LLC Vertex Pharmaceuticals Inc Put Options Transaction History

Two Sigma Securities, LLC

$8.19 Billion
Q2 2024

Put Options

22 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2024 Aug 14, 2024	SELL	$392.81 - $485.53 $432,091 - $534,083	-1,100 Reduced 11.46%	8,500 $3.98 Million
Q1 2024 May 15, 2024	BUY	$407.69 - $446.08 $978,456 - $1.07 Million	2,400 Added 33.33%	9,600 $4.01 Million
Q4 2023 Feb 14, 2024	SELL	$343.0 - $410.68 $1.96 Million - $2.34 Million	-5,700 Reduced 44.19%	7,200 $2.93 Million
Q3 2023 Nov 14, 2023	BUY	$338.18 - $362.46 $3.18 Million - $3.41 Million	9,400 Added 268.57%	12,900 $4.49 Million
Q2 2023 Aug 14, 2023	BUY	$314.42 - $351.91 $251,536 - $281,528	800 Added 29.63%	3,500 $1.23 Million
Q1 2023 May 15, 2023	SELL	$283.23 - $323.1 $934,659 - $1.07 Million	-3,300 Reduced 55.0%	2,700 $850,000
Q4 2022 Feb 14, 2023	BUY	$285.76 - $321.48 $1.06 Million - $1.19 Million	3,700 Added 160.87%	6,000 $1.73 Million
Q3 2022 Nov 14, 2022	BUY	$273.83 - $305.53 $629,809 - $702,718	2,300 New	2,300 $666,000
Q4 2021 Feb 14, 2022	BUY	$177.01 - $223.45 $1.27 Million - $1.61 Million	7,200 Added 480.0%	8,700 $1.91 Million
Q2 2021 Aug 16, 2021	SELL	$187.49 - $221.1 $299,984 - $353,760	-1,600 Reduced 51.61%	1,500 $302,000
Q4 2020 Feb 16, 2021	BUY	$207.01 - $276.09 $186,309 - $248,480	900 Added 40.91%	3,100 $733,000
Q3 2020 Nov 16, 2020	SELL	$255.65 - $303.1 $153,390 - $181,860	-600 Reduced 21.43%	2,200 $599,000
Q2 2020 Sep 10, 2020	BUY	$225.48 - $295.8 $225,480 - $295,800	1,000 Added 55.56%	2,800 $813,000
Q1 2020 May 15, 2020	SELL	$199.77 - $247.81 $1.66 Million - $2.06 Million	-8,300 Reduced 82.18%	1,800 $428,000
Q4 2019 Feb 14, 2020	BUY	$166.71 - $223.91 $1.68 Million - $2.26 Million	10,100 New	10,100 $2.21 Million
Q3 2019 Nov 14, 2019	SELL	$166.23 - $187.09 $565,182 - $636,106	-3,400 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$164.61 - $190.37 $329,220 - $380,740	2,000 Added 142.86%	3,400 $623,000
Q1 2019 May 15, 2019	SELL	$163.73 - $194.7 $1.03 Million - $1.23 Million	-6,300 Reduced 81.82%	1,400 $258,000
Q4 2018 Feb 14, 2019	SELL	$151.91 - $192.21 $2.13 Million - $2.69 Million	-14,000 Reduced 64.52%	7,700 $1.28 Million
Q3 2018 Nov 14, 2018	SELL	$167.73 - $192.74 $1.86 Million - $2.14 Million	-11,100 Reduced 33.84%	21,700 $4.18 Million
Q2 2018 Aug 14, 2018	BUY	$145.72 - $169.96 $3.96 Million - $4.62 Million	27,200 Added 485.71%	32,800 $5.58 Million
Q1 2018 May 15, 2018	BUY	$151.6 - $177.13 $848,960 - $991,928	5,600 New	5,600 $913,000

Others Institutions Holding VRTX

# of Institutions

1,716

Shares Held

225M

Call Options Held

1.19M

Put Options Held

1.56M

Capital World Investors Los Angeles, CA

26.7M
Shares

$13.4 Billion
2.1% of portfolio
Vanguard Group Inc Valley Forge, PA

23M
Shares

$11.5 Billion
0.21% of portfolio
Black Rock Inc. New York, NY

21.3M
Shares

$10.7 Billion
0.23% of portfolio
State Street Corp Boston, MA

11.7M
Shares

$5.89 Billion
0.24% of portfolio
Capital Research Global Investors Los Angeles, CA

8.54M
Shares

$4.29 Billion
0.9% of portfolio

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $129B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Securities, LLC with notifications on news.

Account